# The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma

> **NCT07314255** · — · ACTIVE_NOT_RECRUITING · sponsor: **Jiangxi Provincial Cancer Hospital** · enrollment: 60 (estimated)

## Conditions studied

- PTC
- I-131
- Trop2

## Interventions

- **RADIATION:** radioiodine-131 therapy

## Key facts

- **NCT ID:** NCT07314255
- **Lead sponsor:** Jiangxi Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-18
- **Primary completion:** 2027-06-10
- **Final completion:** 2027-07-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314255, "The Role of Trop2 in Radioactive Iodine-131 Therapy Sensitivity in Papillary Thyroid Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07314255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*